###begin article-title 0
###xml 24 32 24 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPING1</italic>
An association study of SERPING1 gene and age-related macular degeneration in a Han Chinese population
###end article-title 0
###begin p 1
The first four authors contributed equally to this work.
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
###xml 80 88 80 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPING1</italic>
Single nucleotide polymorphisms (SNPs) in the complement component 1 inhibitor (SERPING1) gene have been shown to be significantly associated with age-related macular degeneration (AMD) in Caucasian populations. A replication study of an association between these SNPs and AMD in a Chinese population is reported in this study.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 38 46 38 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPING1</italic>
###xml 166 174 <span type="species:ncbi:9606">patients</span>
###xml 210 213 <span type="species:ncbi:12143?0.0219256434699714">CNV</span>
###xml 230 238 <span type="species:ncbi:9606">patients</span>
Six SNPs, including , , , , , and  in SERPING1 were genotyped in a Han Chinese subject group using the SNaPshot method of ABI. This subject group was composed of 194 patients with choroidal neovascularization (CNV or wet) AMD, 78 patients with soft drusen, and 285 matched controls. P values of the SNPs were calculated using an additive model. Haplotype frequencies between cases and controls were compared by chi2 analysis. The haplotype analysis was performed using Haploview 4.0.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 182 185 <span type="species:ncbi:12143?0.0219256434699714">CNV</span>
None of the six SNPs showed significant association with AMD. None of the major haplotypes were observed to be significantly associated with AMD or choroidal neovascularization AMD (CNV) after a stringent Bonferroni correction.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 28 36 28 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPING1</italic>
We demonstrate that SNPs in SERPING1 are not significantly associated with AMD in the mainland Han Chinese population.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 288 289 288 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 290 291 290 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 660 661 660 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 662 663 662 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 342 350 <span type="species:ncbi:9606">Patients</span>
###xml 527 535 <span type="species:ncbi:9606">Patients</span>
###xml 645 648 <span type="species:ncbi:12143?0.0219256434699714">CNV</span>
Age-related macular degeneration (AMD) is a leading cause of blindness in the elderly population, characterized as chronic and progressive degeneration of photoreceptors, the underlying retinal pigment epithelium (RPE), Bruch's membrane, and possibly, the choriocapillaris in the macula [1,2]. AMD is divided clinically into dry and wet AMD. Patients with dry AMD present with cellular debris (drusen) in or under the retinal pigment epithelium (RPE), irregularities in the pigmentation of the RPE, or geographic atrophy (GA). Patients with exudative or wet AMD are characterized by serous detachment of the RPE or choroidal neovascularization (CNV), or both [1,2]. Advanced AMD, including geographic atrophy or exudative disease, can cause severe vision loss.
###end p 11
###begin p 12
###xml 124 125 124 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 126 127 126 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 254 255 254 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</italic>
###xml 257 260 257 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 263 264 263 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 265 266 265 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 272 278 272 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C2/CFB</italic>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 292 294 292 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 299 301 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 357 372 357 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715/HTRA1</italic>
###xml 448 450 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 451 453 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 539 547 539 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPING1</italic>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 745 747 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 748 750 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
It is believed that AMD is a complex disorder caused by the interaction of multiple genetic and environmental risk factors [3-7]. Identification of AMD related genes has been tremendously successful. Complement pathway genes, including complement factor H (CFH) [2,8-13], C2/CFB [14-16], and C3 [15-17], have been confirmed by many replication studies. The LOC387715/HTRA1 gene has also been verified as a major AMD locus in different populations [18-24]. Recently, SNPs in the serpin peptidase inhibitor, clade G (C1 inhibitor) member 1 (SERPING1) gene showed highly significant genotypic association with age-related macular degeneration in two Caucasian populations [25]. Unfortunately, this finding could not be replicated by other studies [26-34].
###end p 12
###begin p 13
###xml 38 46 38 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPING1</italic>
To further analyze the association of SERPING1 and AMD, we investigated the association between SNPs in this gene and AMD in a mainland Han Chinese population.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Subjects
###end title 15
###begin p 16
###xml 694 696 694 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 697 699 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 700 702 700 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 909 911 909 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 1987 1994 1987 1994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 58 64 <span type="species:ncbi:9606">People</span>
###xml 265 273 <span type="species:ncbi:9606">patients</span>
###xml 491 497 <span type="species:ncbi:9606">People</span>
###xml 604 616 <span type="species:ncbi:9606">participants</span>
###xml 1112 1120 <span type="species:ncbi:9606">Patients</span>
###xml 1155 1158 <span type="species:ncbi:12143?0.0219256434699714">CNV</span>
###xml 1160 1163 <span type="species:ncbi:12143?0.0219256434699714">CNV</span>
###xml 1247 1255 <span type="species:ncbi:9606">patients</span>
###xml 1257 1265 <span type="species:ncbi:9606">Patients</span>
###xml 1323 1331 <span type="species:ncbi:9606">patients</span>
###xml 1355 1363 <span type="species:ncbi:9606">patients</span>
###xml 1465 1471 <span type="species:ncbi:9606">People</span>
###xml 1500 1508 <span type="species:ncbi:9606">patients</span>
###xml 1545 1551 <span type="species:ncbi:9606">People</span>
###xml 1701 1707 <span type="species:ncbi:9606">People</span>
The Institutional Review Boards of the Sichuan Provincial People's Hospital, Xinhua Hospital of Shanghai Jiao Tong University, and Zhongshan Ophthalmic Center, China approved this study. All subjects provided informed consent before participation in the study. AMD patients and normal age-matched controls, including individuals with a normal eye examination (individuals age 60 years or older with no drusen or RPE changes), were recruited in the ophthalmology clinic at Sichuan Provincial People's Hospital, Xinhua Hospital of Shanghai Jiao Tong University, and Zhongshan Ophthalmic Center, China. All participants went through a standard examination protocol as in the previous description [19,24,27]. Grading was performed using a standard grid classification suggested by the International ARM Epidemiological Study Group for age-related maculopathy (ARM) and the age-related macular degeneration group [27]. All abnormalities in the macula were characterized according to the type, size and number of drusen, and hyperpigmentation or hypopigmentation, as well as AMD stages as defined by AREDS 1-5 stages. Patients with clinical features of AMD and CNV (CNV from other causes was excluded), with or without drusen, were diagnosed as wet AMD patients. Patients with only soft drusen were diagnosed as drusen (dry AMD) patients. In total, 194 wet AMD patients (Eight from Zhongshan Ophthalmic Center, 28 from Xinhua Hospital, 158 from of the Sichuan Provincial People's Hospital), 78 soft drusen patients (all from of the Sichuan Provincial People's Hospital), and 285 normal matched controls (Eight from Zhongshan Ophthalmic Center, 30 from Xinhua Hospital and 247 from of the Sichuan Provincial People's Hospital) were recruited. In the normal matched controls, all individuals underwent an eye exam, no signs of early AMD, such as soft drusen or irregular pigmentations of the RPE in the macular area, were observed. Clinical information about the cases and controls is listed in Table 1.
###end p 16
###begin title 17
Characteristics of amd cases and controls matched for ages and ethnicity.
###end title 17
###begin title 18
Selection of tag and functional SNPs
###end title 18
###begin p 19
###xml 157 165 157 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPING1</italic>
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
We used the data of the Han Chinese Beijing population in  of the international HapMap project and previous studies to select tag SNPs or functional SNPs in SERPING1 [26,28] for this study. Six SNPs were selected for genotyping, including  upstream of the transcription start site (-2877 bases),  in intron 2,  (A56V) in exon 3, ,  in intron 6, and  (M480V) in exon 8.
###end p 19
###begin title 20
Genotyping
###end title 20
###begin p 21
###xml 637 645 637 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPING1</italic>
###xml 705 712 705 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
Blood from each subject was drawn and collected in an EDTA-containing tube. Genomic DNA was extracted from the blood by a Gentra Puregene Blood DNA kit (Minneapolis, MN). SNP genotyping was performed by the dye terminator-based SNaPshot method (Applied Biosystems, Foster City, CA). SNP analysis was performed on the ABI 3130 genetic analyzer (Applied Biosystems). Genotypes of the SNPs were determined by Genemapper software (Applied Biosystems). All SNPs reported in this manuscript had a genotyping success rate >96 percent and accuracy as judged by random re-genotyping of 10 percent of the samples in the subject group. Six SNPs in SERPING1 were genotyped. The PCR and SNaPshot primers are listed in Table 2.
###end p 21
###begin title 22
Genotyping primers.
###end title 22
###begin title 23
Haplotype analysis
###end title 23
###begin p 24
Haplotype analysis was performed using . We performed the haplotype analysis following the instructions from the . If the genotype was not available, the genotype was set as 0.
###end p 24
###begin title 25
Statistical analysis
###end title 25
###begin p 26
###xml 80 81 78 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 229 230 225 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 322 323 316 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 429 431 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 432 434 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
Hardy-Weinberg equilibrium (HWE) for each SNP polymorphism was tested by the chi2 test with df=1. P values of the SNPs were calculated using an additive model. Haplotype frequencies between cases and controls were compared by chi2 analysis. The unadjusted odds ratios of the alleles and genotypes were estimated by the chi2 test. All statistical analyses were performed using the software SPSS, (SPSS, Chicago, IL) version 10.0 [18-24].
###end p 26
###begin title 27
Results
###end title 27
###begin title 28
Single nucleotide polymorphism analysis
###end title 28
###begin p 29
###xml 111 118 111 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 148 155 148 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 504 511 502 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 585 593 583 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPING1</italic>
###xml 629 631 627 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 781 784 <span type="species:ncbi:12143?0.0219256434699714">CNV</span>
All six SNPs selected were successfully genotyped and all of these SNPs were within HWE in both case (p>0.001, Table 3) and control groups (p>0.05, Table 3). The SNP frequencies in this study were similar to those of Han Chinese Beijing (HCB) available in HapMap3 in the International  Project. None of the six SNPs showed significant association with AMD or subphenotypes of AMD including wet AMD or soft drusen, which are landmarks of early AMD even before a stringent Bonferroni correction (p>/=0.05, Table 3). SNP  was reported to be the most significant association of SNP in the SERPING1 gene with AMD in previous studies [25]. Although  showed high polymorphism, no association between this SNP and AMD was observed in the Chinese population (p=0.76 for all AMD; p=0.61 for CNV AMD; p=0.77 for soft drusen).
###end p 29
###begin title 30
###xml 53 61 53 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPING1</italic>
Association between subphenotypes of AMD ANS SNPS in SERPING1 in the Han Chinese subject group.
###end title 30
###begin title 31
Haplotype association analysis
###end title 31
###begin p 32
###xml 335 342 335 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 405 412 405 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 515 522 515 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 553 560 553 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 679 686 679 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 796 803 796 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 975 977 975 977 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 979 986 979 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 1100 1107 1100 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 1200 1207 1200 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 1358 1365 1358 1365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
We then performed haplotype analysis using Haploview 4.0, and 14, 15, and 14 haplotypes were observed in the AMD-control, wet AMD-control, and drusen-control groups, respectively. We found that haplotype TGTGCG and haplotype CGCGCG were shown to have a significant difference between both AMD-control (p=0.0064, p=0.006, respectively, Table 4) and wet AMD-control groups (p=0.0042, p=0.025, respectively, Table 4). The haplotype CGTGCG was shown to have a significant difference between both AMD-control (p=0.0102, Table 4) and drusen-control (p=0.032, Table 4). In addition, the haplotype CGTGTA was shown to have a significant difference between wet AMD and controls (p=0.026, Table 4). But none of the haplotypes were shown to have a significant difference between cases and controls (p>0.05, Table 4) after a stringent Bonferroni correction. On the other hand, the haplotype CGTGCA was shown to be significantly associated with soft drusen in our subject group (p=7.87x10-5, Table 4) with frequencies of 0.11 in cases and 0.03 in controls, even after a stringent Bonferroni correction (p=0.0011, Table 4). This haplotype conferred a 3.72-fold (95% CI: 1.83-7.54) increased likelihood of dry AMD (Table 4). Additionally, the haplotype CGTACA was also shown to have a significant difference between both all AMD-control and wet AMD-control groups (p<0.05, Table 4) after a stringent Bonferroni correction. However, the frequency of this haplotype was low and it was absent in the controls.
###end p 32
###begin title 33
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPING1</italic>
SERPING1 haplotype association with AMD in the Han Chinese subject group.
###end title 33
###begin title 34
Discussion
###end title 34
###begin p 35
###xml 49 52 49 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C2/BF</italic>
###xml 65 67 65 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 69 70 69 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 71 72 71 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 92 107 92 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715/HTRA1</italic>
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 383 391 383 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPING1</italic>
###xml 485 493 485 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPING1</italic>
###xml 521 529 521 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPING1</italic>
###xml 674 682 674 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPING1</italic>
###xml 778 780 778 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 781 783 781 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 867 869 867 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 955 963 955 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPING1</italic>
###xml 1180 1181 1180 1181 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1188 1189 1188 1189 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1473 1475 1473 1475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 1476 1478 1476 1478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 1503 1505 1503 1505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 1581 1589 1581 1589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPING1</italic>
###xml 1682 1684 1682 1684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
###xml 1744 1752 1744 1752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPING1</italic>
###xml 1861 1869 1861 1869 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPING1</italic>
###xml 2159 2167 2159 2167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPING1</italic>
###xml 3159 3166 3159 3166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 2084 2087 <span type="species:ncbi:12143?0.0219256434699714">CNV</span>
Although genes in complement pathways, including CFH, C2/BF, and C3 [2,8-17] and chr.10q26 (LOC387715/HTRA1) [18-24], have been identified as related to AMD, these loci could not explain all genetic contributions to AMD, suggesting that additional genetic variants related to AMD have not yet been found. Based on the candidate gene approach, Ennis et al. [25] reported that SNPs in SERPING1 were significantly associated with AMD in two Caucasian populations. Additional evidence for SERPING1 involving AMD includes: 1) SERPING1 gene encoding C1INH plays an important role in complement pathways, which have been confirmed to participate in the pathogenesis of AMD; and 2) SERPING1 was expressed in both retinal and RPE-choroid layers in RT-PCR and immunofluorescence studies [25,29]. AMD affection status was correlated with increased abundance of choroidal C1INH [29]. Complement activation pathways include lectin, classical and alternative pathways. SERPING1 encodes C1INH, an inhibitor of the classical and lectin pathways of complement activation. The classical complement pathway is initiated by the C1 complex, which comprises a C1q hexamer complex with a zymogenic (C1r)2-(C1s) 2). SERPING1 irreversibly inhibits C1r and C1s, MASP-1 (mannan-binding lectin serine peptidase 1), and MASP-2 (mannan-binding lectin serine peptidase 2, the C1s ortholog in the lectin pathway), as well as modulating the complement activation through inhibition unrelated to proteases [30-33]. However, Park et al. [26] were unable to replicate the association between the genetic variation in SERPING1 and AMD in two large and well characterized Caucasian subject groups, and Allikmets et al. [34] were also unable to replicate the association between  in SERPING1 and AMD. Additional replication studies, especially of a different ethnicity, are important to determine if SERPING1 is really associated with AMD. None of the six SNPs showed significant association with AMD and none of the major haplotypes were observed to be significantly associated with AMD or choroid neovascularization AMD (CNV) after a stringent Bonferroni correction in our study, suggesting that SERPING1 may not be related to AMD in the Han Chinese population. In the haplotype analysis, none of the SNPs tagged the significant haplotypes. Because half of samples' genotype data for  and  was not available in the HapMap3 for the Chinese, we cannot compare the haplotype frequencies to those in the HapMap. Although four haplotypes including TGTGCG, CGCGCG, CGTGCG, and CGTGTA were shown to have significant associations with different subphenotypes of AMD, anymore after a stringent Bonferroni correction, the significant associations no longer existed, suggesting that these haplotypes were not specifically associated with AMD. Since the haplotype CGTACA was rare in all AMD (3%) and wet groups (3%), and absent in the drusen group and controls, we think that the significant association between this haplotype and AMD is not reliable. The haplotype CGTGCA was shown to be significantly associated with soft drusen in the subject group even after a stringent Bonferroni correction (p=0.0011, Table 4). Further replication studies are needed to clarify the current situation because of the limited number of soft drusen samples in this study.
###end p 35
###begin title 36
Acknowledgments
###end title 36
###begin p 37
###xml 31 39 <span type="species:ncbi:9606">patients</span>
We thank the participating AMD patients and their families. The authors acknowledge the following grant support (to Z. Yang): Department of Science and Technology of Sichuan Province (04JY029-045, 05ZQ026-018); Natural Science Foundation of China (30671182, 30771220).
###end p 37
###begin title 38
References
###end title 38
###begin article-title 39
Age-related macular degeneration.
###end article-title 39
###begin article-title 40
Complement factor H polymorphism in age-related macular degeneration.
###end article-title 40
###begin article-title 41
Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits.
###end article-title 41
###begin article-title 42
The genetics of age-related macular degeneration: a review of progress to date.
###end article-title 42
###begin article-title 43
CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration.
###end article-title 43
###begin article-title 44
The LOC387715 gene, smoking, body mass index, environmental associations with advanced age-related macular degeneration.
###end article-title 44
###begin article-title 45
Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration.
###end article-title 45
###begin article-title 46
Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration.
###end article-title 46
###begin article-title 47
Complement factor H variant increases the risk of age-related macular degeneration.
###end article-title 47
###begin article-title 48
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration.
###end article-title 48
###begin article-title 49
Complement factor H polymorphism and age-related macular degeneration.
###end article-title 49
###begin article-title 50
CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration.
###end article-title 50
###begin article-title 51
Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration.
###end article-title 51
###begin article-title 52
AMD Genetics Clinical Study Group, Hageman GS, Dean M, Allikmets R. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration.
###end article-title 52
###begin article-title 53
Complement C3 variant and the risk of age-related macular degeneration.
###end article-title 53
###begin article-title 54
Variation in complement factor 3 is associated with risk of age-related macular degeneration.
###end article-title 54
###begin article-title 55
Deletion of CFHR3 and CFHR1 genes in age-related macular degeneration.
###end article-title 55
###begin article-title 56
HTRA1 promoter polymorphism in wet age-related macular degeneration.
###end article-title 56
###begin article-title 57
HTRA1 variant increases risk to neovascular age-related macular degeneration in Chinese population.
###end article-title 57
###begin article-title 58
HTRA1 polymorphism in dry and wet age-related macular degeneration.
###end article-title 58
###begin article-title 59
HTRA1 variants in exudative age-related macular degeneration and interactions with smoking and CFH.
###end article-title 59
###begin article-title 60
HTRA1 promoter polymorphism predisposes Japanese to age-related macular degeneration.
###end article-title 60
###begin article-title 61
LOC387715/HTRA1 variants in polypoidal choroidal vasculopathy and age-related macular degeneration in a Japanese population.
###end article-title 61
###begin article-title 62
A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration.
###end article-title 62
###begin article-title 63
Association between the SERPING1 gene and age-related macular degeneration: a two-stage case-control study.
###end article-title 63
###begin article-title 64
Common variation in the SERPING1 gene is not associated with age-related macular degeneration in two independent groups of subjects.
###end article-title 64
###begin article-title 65
An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group.
###end article-title 65
###begin article-title 66
###xml 59 64 <span type="species:ncbi:9606">human</span>
Localization of complement 1 inhibitor (C1INH/SERPING1) in human eyes with age-related macular degeneration.
###end article-title 66
###begin article-title 67
Activation of C1r by proteolytic cleavage.
###end article-title 67
###begin article-title 68
###xml 66 71 <span type="species:ncbi:9606">human</span>
Interaction of C1-inhibitor with the C1r and C1s subcomponents in human C1.
###end article-title 68
###begin article-title 69
Elucidation of the substrate specificity of the MASP-2 protease of the lectin complement pathway and identification of the enzyme as a major physiological target of the serpin, C1-inhibitor.
###end article-title 69
###begin article-title 70
Modulation of the proteolytic activity of the complement protease C1s by polyanions: implications for polyanion-mediated acceleration of interaction between C1s and SERPING1.
###end article-title 70
###begin article-title 71
The SERPING1 gene and age-related macular degeneration.
###end article-title 71

